Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page
- Check2 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, indicating a platform/site release rather than a change to the study record itself.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor site maintenance update with no changes to study data or content.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now displays Revision: v3.4.2 and removes the earlier government-funding notices and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.